Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer

Detalles Bibliográficos
Autores principales: Suzawa, Ken, Offin, Michael, Schoenfeld, Adam J., Plodkowski, Andrew J., Odintsov, Igor, Lu, Daniel, Lockwood, William W., Arcila, Maria E., Rudin, Charles M., Drilon, Alexander, Yu, Helena A., Riely, Gregory J., Somwar, Romel, Ladanyi, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541452/
https://www.ncbi.nlm.nih.gov/pubmed/31157314
http://dx.doi.org/10.1200/PO.19.00011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541452/
https://www.ncbi.nlm.nih.gov/pubmed/31157314
http://dx.doi.org/10.1200/PO.19.00011

Ejemplares similares